Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
QUANTRX BIOMEDICAL CORP (QTXB)
|
Add to portfolio |
|
|
|
| Price: |
$0.01
| | Metrics |
| OS: |
78.7
|
M
| |
|
|
| Market cap: |
$787
|
k
| |
|
|
|
Net debt:
|
$1.49
|
M
| |
|
|
|
EV:
|
$2.27
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($41.9)
|
k
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | 0.0 | 0.0 |
| Revenue growth | | | | -100.0% | | -100.0% | -93.6% | -60.2% |
| Cost of goods sold | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 | 0.1 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | -0.1 | -0.1 | 0.2 | -0.1 | 0.0 | 0.0 |
| Gross margin | | | | | 49.1% | | -5394.9% | 18.6% |
| Selling, general and administrative | 0.0 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 | 0.3 | 0.4 |
| Research and development | | | | | | | 0.0 | 0.1 |
| General and administrative | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 |
| EBIT | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 | -0.1 | -0.4 | -0.5 |
| EBIT margin | | | | | 1.5% | | -229941.7% | -18852.1% |
| Pre-tax income | -0.3 | -0.3 | -0.6 | -0.7 | 0.9 | -0.4 | -0.5 | -0.8 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -0.3 | -0.3 | -0.6 | -0.7 | 0.9 | -0.4 | -0.5 | -0.8 |
| Net margin | | | | | 268.0% | | -299859.0% | -34032.3% |
| |
| Diluted EPS | $0.00 | $0.00 | ($0.01) | ($0.01) | $0.01 | ($0.01) | ($0.01) | ($0.01) |
| Shares outstanding (diluted) | 78.7 | 78.7 | 78.7 | 78.7 | 130.4 | 74.2 | 66.8 | 58.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|